Batavia Biosciences is a contract development and manufacturing organization with expertise in viral vaccines, virotherapy, proteins and antibodies. We are not your standard CDMO – our customers regularly refer to us as their product development partner and thought partner.
How Batavia helps to reduce human suffering from infectious diseases and cancer
We accelerate the journey to the clinic by improving product yields, reducing process development time and increasing product stability. Our services and technologies have demonstrated to reduce risks, improve timelines and reduce costs in biopharmaceutical development to ensure the product reaches the patient without any unnecessary delays.
100
experts with industry experience
500
projects successfully completed
97
successful runs under GMP
70
returning customers
Latest resources from learning center
Date: Nov 1-3 Location: Frankfurt, Germany Contact: Pieter-Jan Vos It’s time for one of the best bioprocessing events of the year! Come join us at CPHI Frankfurt at Booth #91G03.…
BARCELONA, Spain — September 15, 2022- Veeva Systems (NYSE: VEEV) today announced Batavia Biosciences selected Veeva Vault Quality Suite to optimize its global quality assurance (QA), unifying content, processes, and…
Date: 24 - 26 October 2022 Location: Leipzig, Germany Contact: Pieter-Jan Vos Are your joining us at the BIO-Europe? Our team looks forward to meeting you in person again at…
Date: 11-14 October Location: Edinburgh, Scotland Contact: Pieter-Jan Vos Meet us at the 29th European Society of Gene and Cell Therapy’s (ESGCT) Annual Meeting in Edinburgh, Scotland. We will be…
Talk to our experts
